Form EFFECT Clearside Biomedical,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 16, 2025 |
| Accession Number: | 0001193125-25-319171 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stellus Private Credit BDC Announces $0.31 Third Quarter 2026 Regular Dividend, Payable Monthly in Increments of $0.1033 in July, August, and September 2026
- CREDIT SUISSE ASSET MANAGEMENT INCOME FUND, INC. ANNOUNCES NAME CHANGE
- CREDIT SUISSE HIGH YIELD CREDIT FUND ANNOUNCES NAME CHANGE
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
